Work for Pieris Pharmaceuticals, Inc. ?

Claim Your Profile

Pieris Pharmaceuticals, Inc.  Logo Image

Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc.  Banner Image

About Pieris Pharmaceuticals, Inc.

51-200 Employees
Based in Boston, Massachusetts

Pieris is a clinical-stage biotechnology company that discovers and develops Anticalin protein-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes inhalable Anticalin proteins to treat respiratory diseases, immuno-oncology multi-specifics tailored for the tumor microenvironment, and a half-life-optimized Anticalin protein to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Anticalin® is a registered trademark of Pieris.

Ticker:
PIRS
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol